Barclays
LRMR icon

Barclays’s Larimar Therapeutics LRMR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$245K Buy
84,860
+30,601
+56% +$88.3K ﹤0.01% 3414
2025
Q1
$116K Sell
54,259
-16,166
-23% -$34.6K ﹤0.01% 3632
2024
Q4
$273K Buy
70,425
+10,393
+17% +$40.3K ﹤0.01% 3366
2024
Q3
$393K Buy
60,032
+45,781
+321% +$300K ﹤0.01% 3123
2024
Q2
$104K Sell
14,251
-3,953
-22% -$28.8K ﹤0.01% 3355
2024
Q1
$138K Sell
18,204
-17,087
-48% -$130K ﹤0.01% 3517
2023
Q4
$160K Buy
35,291
+30,261
+602% +$137K ﹤0.01% 3584
2023
Q3
$20K Sell
5,030
-49,202
-91% -$196K ﹤0.01% 3906
2023
Q2
$170K Buy
54,232
+25,939
+92% +$81.3K ﹤0.01% 3164
2023
Q1
$128K Buy
+28,293
New +$128K ﹤0.01% 3403
2020
Q1
Sell
-236
Closed 3817
2019
Q4
$0 Sell
236
-435
-65% ﹤0.01% 4075
2019
Q3
$0 Buy
671
+231
+53% ﹤0.01% 4291
2019
Q2
$1K Sell
440
-8,575
-95% -$19.5K ﹤0.01% 4170
2019
Q1
$25K Buy
9,015
+7,192
+395% +$19.9K ﹤0.01% 3863
2018
Q4
$9K Sell
1,823
-9,614
-84% -$47.5K ﹤0.01% 3574
2018
Q3
$134K Buy
11,437
+9,746
+576% +$114K ﹤0.01% 3263
2018
Q2
$17K Sell
1,691
-19,187
-92% -$193K ﹤0.01% 3703
2018
Q1
$155K Buy
20,878
+20,863
+139,087% +$155K ﹤0.01% 2974
2017
Q4
$0 Hold
15
﹤0.01% 4130
2017
Q3
$0 Sell
15
-61,054
-100% ﹤0.01% 4079
2017
Q2
$214K Buy
61,069
+49,130
+412% +$172K ﹤0.01% 2403
2017
Q1
$56K Buy
11,939
+5,413
+83% +$25.4K ﹤0.01% 3062
2016
Q4
$20K Buy
6,526
+6,383
+4,464% +$19.6K ﹤0.01% 3083
2016
Q3
$0 Sell
143
-199
-58% ﹤0.01% 4004
2016
Q2
$2K Buy
342
+200
+141% +$1.17K ﹤0.01% 3289
2016
Q1
$1K Sell
142
-8,407
-98% -$59.2K ﹤0.01% 3305
2015
Q4
$52K Buy
8,549
+1,229
+17% +$7.48K ﹤0.01% 2476
2015
Q3
$227K Buy
7,320
+6,950
+1,878% +$216K ﹤0.01% 2074
2015
Q2
$13K Sell
370
-212
-36% -$7.45K ﹤0.01% 3173
2015
Q1
$22K Buy
582
+22
+4% +$832 ﹤0.01% 3069
2014
Q4
$17K Buy
+560
New +$17K ﹤0.01% 3487